INTEGER HOLDINGS CORP
ITGRNYSETrading Snapshot
- Day Range
- $700.58 β $711.16
- 52-Week Range
- $62.00 β $126.80
- Volume
- $3.82B
- Avg Volume
- $3.02B
- Shares Outstanding
- 34.0M
- Next Earnings
- Nov 1, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.85B
- Last Q Revenue
- $464M
- P/E Ratio
- 34.2
- P/S Ratio
- 2.3x
- EPS (TTM)
- $3.78
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β3.0%
Why Investors Own ITGR
- βHigh-growth profile β revenue up +36.4% YoY with expanding US Equity exposure.
- βHealthy economics β 26% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
INTEGER HOLDINGS CORP
ITGRAbout INTEGER HOLDINGS CORP
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
INTEGER HOLDINGS CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ITGR price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
INTEGER HOLDINGS CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.